Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
2-8 moderate to severe migraines/month within the last 3 months
Migraine attacks present for more than 1 year with age of onset of migraines prior to 50 years of age
Migraine attacks, on average, lasting about 4-72 hours if untreated
Less than 15 days with headaches (migraine or non-migraine) per month in each of the 3 months prior to the screening visit
Ability to distinguish migraine attacks from tension/cluster headaches
Participants with contraindications for use of triptans may be included provided they meet all other study entry criteria
You may not be if
History of human immunodeficiency virus disease
History of basilar or hemiplegic migraine
Current diagnosis of major depressive disorder requiring treatment with atypical antipsychotics, schizophrenia, bipolar disorder, or borderline personality disorder
History of nasal surgery in the 6 months preceding the screening visit
History of gallstones or cholecystectomy
History of gastric, or small intestinal surgery (including gastric bypass, gastric banding, gastric sleeve, gastric balloon, etcetera), or other disease or condition (for example, chronic pancreatitis, ulcerative colitis, etcetera) that causes malabsorption.
Body mass index ≥ 33
Hemoglobin A1c ≥6.5%
Clareo Health | Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine
